Topics
High-grade gliomas | Treatment | Radiotherapy | Margins
Home > Publications > Topics > High-grade gliomas > Treatment > Radiotherapy > Margins
Positron emission tomography
Niitsu H, Fukumitsu N, Tanaka K, Mizumoto M, Nakai K, Matsuda M,
Ishikawa E, Hatano K, Hashimoto T, Kamizawa S, Sakurai
H.
Methyl-11C-L-methionine
positron emission tomography for radiotherapy planning for
recurrent malignant glioma.
Ann
Nucl Med. 2024 Feb 14. doi:
10.1007/s12149-024-01901-z. PMID:
38356008. Observational study. ˍ
Different Target Volume Delineations
Qiu Y, Li Y, Cuihong J, Wu X, Liu W, Fan C, Ye X, He L, Xiao S,
Zhao Q, Wu W, Chen K, Tan C, Li Y, Wang H, Liu F.
Toxicity
and Efficacy of Different Target Volume Delineations of
Radiotherapy Based on the Updated RTOG/NRG and EORTC Guidelines in
Patients with Grade 3-4 Glioma: A Randomized Controlled Clinical
Trial.
Int
J Radiat Oncol Biol Phys. 2024 Nov
28:S0360-3016(24)03668-X. doi:
10.1016/j.ijrobp.2024.11.094. PMID:
39615657. Interventional study˰
ˍ
Subventricular zone involvement
Sun F, Zhu Y, Gan G, Xu Y, Xu X.
Therapeutic
and prognostic impact of target volume delineation in
postoperative radiotherapy for high-grade glioma patients with
subventricular zone involvement.
Radiat
Oncol. 2025 Feb 19;20(1):24. doi:
10.1186/s13014-025-02601-2. PMID:
39972483. Observational study. ˍ